ACTH releasing activity of KP-102 (GHRP-2) in rats is mediated mainly by release of CRF

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 371, Issue 1, 2005, Pages 54-60

  Hirotani, Chiharu ^a   Oki, Yutaka ^b   Ukai, Kiyoharu ^a   Okuno, Tadashi ^a   Kurasaki, Shigeru ^a   Ohyama, Tadashi ^a   Doi, Naomi ^a   Sasaki, Ken ^a   Ase, Katsuhiko ^a  

^a KAKEN PHARMACEUTICAL CO LTD   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

ACTH; AVP; CRF; GHRP; Hypothalamus; KP 102

Indexed keywords

ANTISERUM; ARGIPRESSIN; ARGIPRESSIN[1 (3,3 CYCLOPENTAMETHYLENE 3 MERCAPTOPROPIONIC ACID) 2 (O METHYLTYROSINE)]; ASTRESSIN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; PRALMORELIN;

AGONIST; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CORTICOTROPIN RELEASE; DRUG ACTIVITY; DRUG EFFECT; DRUG SCREENING; HYPOPHYSIS CELL; INHIBITION KINETICS; MALE; NONHUMAN; RAT; STRESS;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; ARGININE VASOPRESSIN; CELL SEPARATION; CORTICOTROPIN-RELEASING HORMONE; DRUG SYNERGISM; INJECTIONS, INTRAVENOUS; MALE; OLIGOPEPTIDES; PITUITARY GLAND; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 15044350049     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-004-1009-3     Document Type: Article

References (45)

1. Aguilera G, Wynn PC, Harwood JP, Hauger RL, Millan MA, Grewe C, Catt KJ (1986) Receptor-mediated actions of corticotropin-releasing factor in pituitary gland and nervous system. Neuroendocrinology 43:79-88
2. Aguilera G, Lightman SL, Kiss A (1993) Regulation of the hypothalamic-pituitary-adrenal axis during water deprivation. Endocrinology 132:241-248
3. Antoni FA (1984) Novel ligand specificity of pituitary vasopressin receptors in the rat. Neuroendocrinology 39:186-188
4. Arvat E, di Vito L, Maccagno B, Broglio F, Boghen MF, Deghenghi R, Camanni F, Ghigo E (1997) Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with the effects of GHRH, TRH and hCRF. Peptides 18:885-891
5. Asakawa A, Inui A, Kaga T, Yuzuriha H, Nagata T, Fujimiya M, Katsuura G, Makino S, Fujino MA, Kasuga M (2001) A role of ghrelin in neuroendocrine and behavioral responses to stress in mice. Neuroendocrinology 74:143-147
6. Bowers CY (1993) GH releasing peptides - structure and kinetics. J Pediatr Endocrinol 6:21-31
7. Bowers CY (2001) Unnatural growth hormone-releasing peptide begets natural ghrelin. J Clin Endocrinol Metab 86:1464-1469
8. Broglio F, Benso A, Castiglioni C, Gottero C, Prodam F, Destefanis S, Gauna C, van der Lely AJ, Deghenghi R, Bo M, Arvat E, Ghigo E (2003) The endocrine response to ghrelin as a function of gender in humans in young and elderly subjects. J Clin Endocrinol Metab 88:1537-1542
9. Cheng K, Chan WW, Butler B, Wei L, Schoen WR, Wyvratt MJ Jr, Fisher MH, Smith RG (1993) Stimulation of growth hormone release from rat primary pituitary cells by L-692,429, a novel non-peptidyl GH secretagogue. Endocrinology 132:2729-2731
10. Chu CP, Qiu DL, Kato K, Kunitake T, Watanabe S, Yu NS, Nakazato M, Kannan H (2004) Central stresscopin modulates cardiovascular function through the adrenal medulla in conscious rats. Regul Pept 119:53-59
11. Clark RG, Robinson IC (1985) Growth hormone responses to multiple injections of a fragment of human growth hormone-releasing factor in conscious male and female rats. J Endocrinol 106:281-289
12. Deghenghi R, Boutignon F, Luoni M, Grilli R, Guidi M, Locatelli V (1995) Small peptides as potent releasers of growth hormone. J Pediatr Endocrinol Metab 8:311-313
13. Donaldson CJ, Sutton SW, Perrin MH, Corrigan AZ, Lewis KA, Rivier JE, Vaughan JM, Vale WW (1996) Cloning and characterization of human urocortin. Endocrinology 137:2167-2170
14. Elias KA, Ingle GS, Burnier JP, Hammonds RG, McDowell RS, Rawson TE, Somers TC, Stanley MS, Cronin MJ (1995) In vitro characterization of four novel classes of growth hormone-releasing peptide. Endocrinology 136:5694-5699
15. Frieboes RM, Murck H, Maier P, Schier T, Holsboer F, Steiger A (1995) Growth hormone-releasing peptide-6 stimulates sleep, growth hormone, ACTH and cortisol release in normal man. Neuroendocrinology 61:584-589
16. Gaillard RC, Riondel AM, Ling N, Muller AF (1988) Corticotropin releasing factor activity of CRF 41 in normal man is potentiated by angiotensin II and vasopressin but not by desmopressin. Life Sci 43:1935-1944
17. Ghigo E, Arvat E, Rizzi G, Goffi S, Grottoli S, Mucci M, Boghen MF, Camanni F (1994) Growth hormone-releasing activity of growth hormone-releasing peptide-6 is maintained after short-term oral pretreatment with the hexapeptide in normal aging. Eur J Endocrinol 131:499-503
18. Ghigo E, Arvat E, Broglio F, Giordano R, Gianotti L, Muccioli G, Papotti M, Graziani A, Bisi G, Deghenghi R, Camanni F (1999) Endocrine and non-endocrine activities of growth hormone secretagogues in humans. Horm Res 51:9-15
19. Hartman ML, Farello G, Pezzoli SS, Thorner MO (1992) Oral administration of growth hormone (GH)-releasing peptide stimulates GH secretion in normal men. J Clin Endocrinol Metab 74:1378-1384
20. Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, Hamelin M, Hreniuk DL, Palyha OC, Anderson J, Paress PS, Diaz C, Chou M, Liu KK, McKee KK, Pong SS, Chaung LY, Elbrecht A, Dashkevicz M, Heavens R, Rigby M, Sirinathsinghji DJ, Dean DC, Melillo DG, Van der Ploeg LH (1996) A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273:974-977
21. Inoue K, Valdez GR, Reyes TM, Reinhardt LE, Tabarin A, Rivier J, Vale WW, Sawchenko PE, Koob GF, Zorrilla EP (2003) Human urocortin II, a selective agonist for the type 2 corticotropin-releasing factor receptor, decreases feeding and drinking in the rat. J Pharmacol Exp Ther 305:385-393
22. Ishizaki S, Murase T, Sugimula Y, Kakiya S, Yokoi H, Tachikawa K, Arima H, Miura Y, Oiso Y (2002) Role of ghrelin in the regulation of vasopressin release in conscious rats. Endocrinology 143:1589-1593
23. Jacks T, Hickey G, Judith F, Taylor J, Chen H, Krupa D, Feeney W, Schoen W, Ok D, Fisher M (1994) Effects of acute and repeated intravenous administration of L-692,585, a novel non-peptidyl growth hormone secretagogue, on plasma growth hormone, IGF-1, ACTH, cortisol, prolactin, insulin, and thyroxine levels in beagles. J Endocrinol 143:399-406
24. Kjaer A (1993) Vasopressin as a neuroendocrine regulator of anterior pituitary hormone secretion. Acta Endocrinol (Copenh) 129:489-496
25. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656-660
26. Korbonits M, Kaltsas G, Perry LA, Putignano P, Grossman AB, Besser GM, Trainer PJ (1999a) The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin. J Clin Endocrinol Metab 84: 2489-2495
27. Korbonits M, Little JA, Forsling ML, Tringali G, Costa A, Navarra P, Trainer PJ, Grossman AB (1999b) The effect of growth hormone secretagogues and neuropeptide Y on hypothalamic hormone release from acute rat hypothalamic explants. J Neuroendocrinol 11:521-528
28. Lennard DE, Eckert WA, Merchenthaler I (1993) Corticotropin-releasing hormone neurons hi the paraventricular nucleus project to the external zone of the median eminence: a study combining retrograde labeling with immunocytochemistry. J Neuroendocrinol 5:175-181
29. Lewis K, Li C, Perrin MH, Blount A, Kunitake K, Donaldson C, Vaughan J, Reyes TM, Gulyas J, Fischer W, Bilezikjian L, Rivier J, Sawchenko PE, Vale WW (2001) Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci USA 98:7570-7575
30. Mozid AM, Tringali G, Forsling ML, Hendricks MS, Ajodha S, Edwards R, Navarra P, Grossman AB, Korbonits M (2003) Ghrelin is released from rat hypothalamic explants and stimulates corticotrophin-releasing hormone and arginine-vasopressin. Horm Metab Res 35:455-459
31. Nakagawa T, Ukai K, Ohyama T, Koida M, Okamura H (1996) Effects of the synthesized growth hormone releasing peptide, KP-102, on growth hormone release in sodium glutamate monohydrate-treated low growth rats. Life Sci 59:705-712
32. Okada K, Ishii S, Minami S, Sugihara H, Shibasaki T, Wakabayashi I (1996) Intracerebroventricular administration of the growth hormone-releasing peptide KP-102 increases food intake in free-feeding rats. Endocrinology 137:5155-5158
33. Oki Y, Nicholson WE, Orth DN (1990) Role of protein kinase-C in the adrenocorticotropin secretory response to arginine vasopressin (AVP) and the synergistic response to AVP and corticotropin-releasing factor by perfused rat anterior pituitary cells. Endocrinology 127:350-357
34. Oliver C, Conte-Devolx B, Giraud P, Gillioz P, Lissitzky JC, Boudouresque F (1980) Hypothalamic control of ACTH secretion. Horm Res 13:230-241
35. Pelleymounter MA, Joppa M, Ling N, Foster AC (2004) Behavioral and neuroendocrine effects of the selective CRF2 receptor agonists urocortin II and urocortin III. Peptides 25:659-666
36. Raadsheer FC, Sluiter AA, Ravid R, Tilders FJ, Swaab DF (1993) Localization of corticotropin-releasing hormone (CRF) neurons in the paraventricular nucleus of the human hypothalamus; age-dependent colocalization with vasopressin. Brain Res 615:50-62
37. Raun K, Hansen BS, Johansen NL, Thogersen H, Madsen K, Ankersen M, Andersen PH (1998) Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol 139:552-561
38. Reyes TM, Lewis K, Perrin MH, Kunitake KS, Vaughan J, Arias CA, Hogenesch JB, Gulyas J, Rivier J, Vale WW and Sawchenko PE (2001) Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci USA 98:2843-2848
39. Rivier C, Vale W (1983) Interaction of corticotropin-releasing factor and arginine vasopressin on adrenocorticotropin secretion in vivo. Endocrinology 113:939-942
40. Smith RG, Van der Ploeg LH, Howard AD, Feighner SD, Cheng K, Hickey GJ, Wyvratt MJ Jr, Fisher MH, Nargund RP, Patchett AA (1997) Peptidomimetic regulation of growth hormone secretion. Endocr Rev 18:621-645
41. Takaya K, Ariyasu H, Kanamoto N, Iwakura H, Yoshimoto A, Harada M, Mori K, Komatsu Y, Usui T, Shimatsu A, Ogawa Y, Hosoda K, Akamizu T, Kojima M, Kangawa K, Nakao K (2000) Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocrinol Metab 85:4908-4911
42. Thomas GB, Fairhall KM, Robinson IC (1997) Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats. Endocrinology 138:1585-1591
43. Turkelson CM, Arimura A, Culler MD, Fishback JB, Groot K, Kanda M, Luciano M, Thomas CR, Chang D, Chang JK, Shimizu M (1981) In vivo and in vitro release of ACTH by synthetic CRF. Peptides 2:425-429
44. Wren AM, Small CJ, Fribbens CV, Neary NM, Ward HL, Seal LJ, Ghatei MA, Bloom SR (2002) The hypothalamic mechanisms of the hypophysiotropic action of ghrelin. Neuroendocrinology 76:316-324
45. Wu D, Chen C, Katoh K, Zhang J, Clarke IJ (1994) The effect of GH-releasing peptide-2 (GHRP-2 or KP 102) on GH secretion from primary cultured ovine pituitary cells can be abolished by a specific GH-releasing factor (GRF) receptor antagonist. J Endocrinol 140:R9-R13